These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 26299768)
1. MicroRNA-101 inhibits the migration and invasion of intrahepatic cholangiocarcinoma cells via direct suppression of vascular endothelial growth factor-C. Deng G; Teng Y; Huang F; Nie W; Zhu L; Huang W; Xu H Mol Med Rep; 2015 Nov; 12(5):7079-85. PubMed ID: 26299768 [TBL] [Abstract][Full Text] [Related]
2. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152. Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-101 induces apoptosis in cisplatin-resistant gastric cancer cells by targeting VEGF-C. Li G; Yang F; Gu S; Li Z; Xue M Mol Med Rep; 2016 Jan; 13(1):572-8. PubMed ID: 26573417 [TBL] [Abstract][Full Text] [Related]
4. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery. Shi RY; Yang XR; Shen QJ; Yang LX; Xu Y; Qiu SJ; Sun YF; Zhang X; Wang Z; Zhu K; Qin WX; Tang ZY; Fan J; Zhou J Cancer; 2013 Mar; 119(5):993-1003. PubMed ID: 23132676 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer. Guan H; Dai Z; Ma Y; Wang Z; Liu X; Wang X Int J Mol Med; 2016 Jun; 37(6):1643-51. PubMed ID: 27082308 [TBL] [Abstract][Full Text] [Related]
6. MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma. Xiong X; Sun D; Chai H; Shan W; Yu Y; Pu L; Cheng F Biochem Biophys Res Commun; 2015 Sep; 465(2):262-9. PubMed ID: 26255969 [TBL] [Abstract][Full Text] [Related]
7. MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN. Wang LJ; He CC; Sui X; Cai MJ; Zhou CY; Ma JL; Wu L; Wang H; Han SX; Zhu Q Oncotarget; 2015 Mar; 6(8):5932-46. PubMed ID: 25803229 [TBL] [Abstract][Full Text] [Related]
8. MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression. Li J; Tian F; Li D; Chen J; Jiang P; Zheng S; Li X; Wang S FEBS Lett; 2014 Sep; 588(18):3491-500. PubMed ID: 25131931 [TBL] [Abstract][Full Text] [Related]
9. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling. Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939 [TBL] [Abstract][Full Text] [Related]
10. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway. Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691 [TBL] [Abstract][Full Text] [Related]
11. Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma. Wang J; Zhang K; Wang J; Wu X; Liu X; Li B; Zhu Y; Yu Y; Cheng Q; Hu Z; Guo C; Hu S; Mu B; Tsai CH; Li J; Smith L; Yang L; Liu Q; Chu P; Chang V; Zhang B; Wu M; Jiang X; Yen Y Oncotarget; 2015 Aug; 6(22):18905-20. PubMed ID: 26056085 [TBL] [Abstract][Full Text] [Related]
12. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications. Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422 [TBL] [Abstract][Full Text] [Related]
14. Enforced expression of miR-101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase-2 pathway. Bu Q; Fang Y; Cao Y; Chen Q; Liu Y Mol Med Rep; 2014 Oct; 10(4):2203-9. PubMed ID: 25109742 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b. Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763 [TBL] [Abstract][Full Text] [Related]
16. Co‑expression of the carbamoyl‑phosphate synthase 1 gene and its long non‑coding RNA correlates with poor prognosis of patients with intrahepatic cholangiocarcinoma. Ma SL; Li AJ; Hu ZY; Shang FS; Wu MC Mol Med Rep; 2015 Dec; 12(6):7915-26. PubMed ID: 26499888 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma. Li H; Zhou ZQ; Yang ZR; Tong DN; Guan J; Shi BJ; Nie J; Ding XT; Li B; Zhou GW; Zhang ZY Hepatology; 2017 Jul; 66(1):136-151. PubMed ID: 28194813 [TBL] [Abstract][Full Text] [Related]
18. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma. Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431 [TBL] [Abstract][Full Text] [Related]
19. Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression. Huang CK; Aihara A; Iwagami Y; Yu T; Carlson R; Koga H; Kim M; Zou J; Casulli S; Wands JR Cancer Lett; 2016 Sep; 380(1):153-62. PubMed ID: 27364974 [TBL] [Abstract][Full Text] [Related]
20. FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition. Lv B; Ma L; Tang W; Huang P; Yang B; Wang L; Chen S; Gao Q; Zhang S; Xia J Cell Physiol Biochem; 2018; 48(1):158-172. PubMed ID: 30001540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]